Standardization in immunohistology.

作者: Anthony S.-Y. Leong , Trishe Y.-M. Leong

DOI: 10.1007/978-1-61779-055-3_3

关键词: BiopsyArtificial intelligenceFixation (histology)Machine learningTissue ProcessingImmunostainingAntigen retrievalStandardizationTissue PreservationMorphologic diagnosisComputer science

摘要: The rapid acceptance of immunohistology as an invaluable adjunct to morphologic diagnosis has been possible because the development new and more sensitive antibodies detection systems that allow its application formalin-fixed, paraffin-embedded tissue (FFPT). More importantly, antigen-retrieval techniques have resulted in some degree consistency allowing be used reliably a diagnostic tool. advent prognostic predictive biomarkers, desire for individualized therapy mounting pressure employ immunohistological assay quantitative manner. While it was not major issue when technique employed qualitative manner, numerous variables preanalytical analytical phases test procedure influence immunoexpression proteins FFPT become critical standardization. Tissue fixation is pivotal antigen preservation but exposure fixative prior accessioning by laboratory controlled. Antigen retrieval, crucial phase, continues empirical manner with actual mechanism action remaining elusive. There great variation reagents, methodology, duration processing immunostaining procedure, are standardized between laboratories. many these offset which enables wide range antigens FFPT, method itself standardized. This myriad makes inappropriate provide meaningful comparisons results obtained different laboratories even same laboratory, current practice, each specimen experiences variables. Furthermore, interpretation exist cutoff thresholds positivity differ. Failure recognize false-positive false-negative stains leads further errors measurement. Many problems relating technology originate from failure this other histological involves steps cannot monitored until end result attained. several remedial measures can suggested address problems, accurate reproducible assessment immunostains presently remains elusive important impact on biopsy -cannot

参考文章(101)
Inti Zlobec, Russell Steele, René P Michel, Carolyn C Compton, Alessandro Lugli, Jeremy R Jass, Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer Modern Pathology. ,vol. 19, pp. 1236- 1242 ,(2006) , 10.1038/MODPATHOL.3800642
A S-Y Leong, S Vinyuvat, C Suthipintawong, J Milios, A comparative study of cell proliferation markers in breast carcinomas. Clinical Molecular Pathology. ,vol. 48, ,(1995) , 10.1136/MP.48.2.M83
Fred R. Hirsch, Rafal Dziadziuszko, Nick Thatcher, Helen Mann, Claire Watkins, Dinah V. Parums, Georgina Speake, Brian Holloway, Paul A. Bunn, Wilbur A. Franklin, Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer. Cancer. ,vol. 112, pp. 1114- 1121 ,(2008) , 10.1002/CNCR.23282
D. Hopwood, G. Yeaman, G. Milne, Differentiating the effects of microwave and heat on tissue proteins and their crosslinking by formaldehyde. Histochemical Journal. ,vol. 20, pp. 341- 346 ,(1988) , 10.1007/BF01002727
Anthony S-Y Leong, Mark Formby, Zenobia Haffajee, Megan Clarke, Adrienne Morey, Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISH. Applied Immunohistochemistry & Molecular Morphology. ,vol. 14, pp. 384- 389 ,(2006) , 10.1097/01.PAI.0000210415.53493.D4
Noël Dybdal, Grazyna Leiberman, Steven Anderson, Bryan McCune, Alex Bajamonde, Robert L. Cohen, Robert D. Mass, Corsee Sanders, Michael F. Press, Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab. Breast Cancer Research and Treatment. ,vol. 93, pp. 3- 11 ,(2005) , 10.1007/S10549-004-6275-8